OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current clinical application of lutetium‑177 in solid tumors (Review)
Tingting Niu, Fan Mi, Binwei Lin, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 8
Tingting Niu, Fan Mi, Binwei Lin, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 8
Showing 8 citing articles:
Radiopharmaceuticals in nasopharyngeal Cancer
Xiao‐Quan Xu, Xuemei Tang, Wan-yin Wu, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108281-108281
Closed Access | Times Cited: 1
Xiao‐Quan Xu, Xuemei Tang, Wan-yin Wu, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108281-108281
Closed Access | Times Cited: 1
Efficient internalization of nano architectured 177Lu-hyaluronic acid@ zirconium-based metal-organic framework for the treatment of neuroblastoma: Unravelling toxicity, stability, radiolabelling and bio-distribution
Sanjay Kulkarni, Abhijeet Pandey, Soji Soman, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134381-134381
Open Access | Times Cited: 5
Sanjay Kulkarni, Abhijeet Pandey, Soji Soman, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134381-134381
Open Access | Times Cited: 5
A PLC based semi-automated extraction chromatographic separation system for the isolation of medical grade no-carrier-added lutetium-177 for targeted cancer therapy
Dheeraj Kumar, Aaditya Shah, Varun Nair, et al.
Reaction Chemistry & Engineering (2025)
Closed Access
Dheeraj Kumar, Aaditya Shah, Varun Nair, et al.
Reaction Chemistry & Engineering (2025)
Closed Access
Cost-utility analysis of 177Lu-PSMA-617 radioligand therapy in second-line and third-line treatment for metastatic castration-resistant prostate cancer (mCRPC) in Germany
Carolin Brinkmann, Richard P. Baum, Tom Stargardt
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Carolin Brinkmann, Richard P. Baum, Tom Stargardt
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
<sup>177</sup>Lu Anti-angiogenic Radioimmunotherapy Targeting ATP synthase in Gastric Cancer Model
Bok-Nam Park, Young‐Sil An, Sumin Kim, et al.
(2024)
Open Access
Bok-Nam Park, Young‐Sil An, Sumin Kim, et al.
(2024)
Open Access
177Lu Anti-Angiogenic Radioimmunotherapy Targeting ATP Synthase in Gastric Cancer Model
Bok-Nam Park, Young‐Sil An, Su-Min Kim, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 51-51
Open Access
Bok-Nam Park, Young‐Sil An, Su-Min Kim, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 51-51
Open Access
Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology
Katsumi Tomiyoshi, Lydia Wilson, Firas Mourtada, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1458-1458
Open Access
Katsumi Tomiyoshi, Lydia Wilson, Firas Mourtada, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1458-1458
Open Access
Improvement of End-of-Synthesis Radiochemical Purity of 177Lu-DOTA-PSMA-Ligands with Alternative Synthesis Approaches: Conversion Upswing and Side-Products Minimization
А. А. Ларенков, Yu. A. Mitrofanov, Marat Rakhimov
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1535-1535
Open Access
А. А. Ларенков, Yu. A. Mitrofanov, Marat Rakhimov
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1535-1535
Open Access
